IL61376A - Trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives and pharmaceutical compositions containing them - Google Patents

Trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives and pharmaceutical compositions containing them

Info

Publication number
IL61376A
IL61376A IL61376A IL6137680A IL61376A IL 61376 A IL61376 A IL 61376A IL 61376 A IL61376 A IL 61376A IL 6137680 A IL6137680 A IL 6137680A IL 61376 A IL61376 A IL 61376A
Authority
IL
Israel
Prior art keywords
tetrahydro
trans
phenyl
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL61376A
Other languages
English (en)
Other versions
IL61376A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26782055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL61376(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of IL61376A0 publication Critical patent/IL61376A0/xx
Publication of IL61376A publication Critical patent/IL61376A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/16Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/21Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL61376A 1979-11-01 1980-10-30 Trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives and pharmaceutical compositions containing them IL61376A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9023779A 1979-11-01 1979-11-01
US06/184,447 US4556676A (en) 1979-11-01 1980-09-05 Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine

Publications (2)

Publication Number Publication Date
IL61376A0 IL61376A0 (en) 1980-12-31
IL61376A true IL61376A (en) 1983-10-31

Family

ID=26782055

Family Applications (1)

Application Number Title Priority Date Filing Date
IL61376A IL61376A (en) 1979-11-01 1980-10-30 Trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US4556676A (no)
EP (1) EP0028901B1 (no)
KR (1) KR840002021B1 (no)
AR (2) AR225196A1 (no)
AT (1) ATE2667T1 (no)
AU (1) AU517842B2 (no)
CA (1) CA1130816A (no)
DE (1) DE3062226D1 (no)
DK (1) DK149308C (no)
ES (2) ES8201948A1 (no)
FI (1) FI68807C (no)
GR (1) GR70782B (no)
IE (1) IE50396B1 (no)
IL (1) IL61376A (no)
NO (1) NO149102C (no)
PH (1) PH15468A (no)
PT (1) PT72005B (no)
YU (2) YU41744B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
US4866208A (en) * 1981-12-21 1989-09-12 The Dow Chemical Company Meta-phenylene diamine derivatives
US4839104A (en) * 1987-06-11 1989-06-13 Pfizer, Inc. Process for preparing sertraline intermediates
US4777288A (en) * 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
FR2623802B1 (fr) * 1987-11-26 1990-05-04 Lucien Laboratoires Derives d'amino-4 trifluoromethyl-1 tetralines. leur preparation et leur application en therapeutique
FR2642065B1 (fr) * 1989-01-24 1991-05-24 Lipha Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant
FR2665443B1 (fr) * 1990-08-03 1992-11-06 Lucien Laboratoires Derives d'amino-4-methyl-1-tetralines, leur preparation et leur application en therapeutique.
US5082970A (en) * 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
GB9114948D0 (en) * 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
US5196607A (en) * 1992-02-14 1993-03-23 Pfizer Inc. Process for preparing ketone enantiomer
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5466880A (en) * 1992-09-15 1995-11-14 Pfizer Inc. Process for preparing ketone enantiomer
WO1994022495A1 (en) * 1993-03-31 1994-10-13 The Trustees Of The University Of Pennsylvania Dopamine d-3 and serotonin (5-ht1a) receptor ligands and imaging agents
EP0724552B1 (en) * 1993-11-30 1997-10-29 Pfizer Inc. Process for preparing a chiral tetralone
US6410794B1 (en) 1994-12-16 2002-06-25 Uop Llc Process for preparation of pharmaceutically desired chiral tetralone from tetralones
US6455736B1 (en) 1994-12-16 2002-09-24 Uop Llc Process for preparation of pharmaceutically desired sertraline and sertraline analogs
HU222341B1 (hu) * 1996-12-18 2003-06-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás sertralin előállítására és az eljárásban alkalmazott intermedier
IN182588B (no) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IN187170B (no) 2000-01-04 2002-02-23 Sun Pharmaceutical Ind Ltd
DE10006411C2 (de) * 2000-02-14 2002-03-07 Huf Huelsbeck & Fuerst Gmbh Elektronischer Zündanlaßschalter für Kraftfahrzeuge und Reserveschlüssel zur Betätigung desselben
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US6482440B2 (en) 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
US6723878B2 (en) 2001-06-15 2004-04-20 Orion Corporation Fermion Method for preparing sertraline
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
JP4610336B2 (ja) * 2002-09-16 2011-01-12 セプラコール インク. トランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−1−ナフタレンアミン及びそのホルムアミドによる中枢神経系障害の治療
EP1545485A2 (en) * 2002-09-16 2005-06-29 Sepracor Inc. Treatment of cns disorders with trans-4- (3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
US20060014838A1 (en) * 2004-07-14 2006-01-19 Sudhakar Valluri Process for converting trans-sertraline to cis-sertraline
US20080293726A1 (en) 2005-07-06 2008-11-27 Sepracor Inc. Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
CN103588659A (zh) 2006-03-31 2014-02-19 赛诺维信制药公司 手性酰胺和胺的制备
EP2043745A2 (en) * 2006-05-31 2009-04-08 SEPRACOR Inc Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide
WO2007146796A2 (en) * 2006-06-13 2007-12-21 Ramot At Tel-Aviv University Ltd. Antiproliferative compounds, compositions and methods of use
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
KR20170005088A (ko) * 2014-05-13 2017-01-11 선오비온 파마슈티컬스 인코포레이티드 Adhd의 치료를 위한 방법 및 다소트랄린의 투약량
WO2015175514A1 (en) * 2014-05-13 2015-11-19 Sunovion Pharmaceuticals Inc. Methods and compositions of dasotraline for treatment of adhd
WO2016046669A2 (en) * 2014-09-27 2016-03-31 Mohan M Alapati Compositions and methods for the treatment of depression and neurological diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB793853A (en) * 1954-09-15 1958-04-23 Schering Ag Manufacture of new 3-amino-indanes
DE1098511B (de) * 1959-11-21 1961-02-02 Schering Ag Verfahren zur Abtrennung von analgetisch wirksamen d-1-Phenyl-3-dimethylaminoindan
US3704323A (en) * 1969-12-23 1972-11-28 Squibb & Sons Inc Indane derivatives
GB1420472A (en) * 1972-09-27 1976-01-07 Pfizer Aminophenyltetralin compounds
US4029731A (en) * 1974-11-06 1977-06-14 Pfizer Inc. Aminophenyltetralin compounds
US4045488A (en) * 1974-11-06 1977-08-30 Pfizer Inc. Aminophenyltetralin compounds

Also Published As

Publication number Publication date
ES496441A0 (es) 1982-01-16
IE802260L (en) 1981-05-01
US4556676A (en) 1985-12-03
CA1130816A (en) 1982-08-31
YU41744B (en) 1987-12-31
EP0028901A1 (en) 1981-05-20
AR229106A1 (es) 1983-06-15
AR225196A1 (es) 1982-02-26
ES8201948A1 (es) 1982-01-16
NO149102C (no) 1984-02-15
FI68807B (fi) 1985-07-31
EP0028901B1 (en) 1983-03-02
AU517842B2 (en) 1981-08-27
DK462480A (da) 1981-05-02
NO803259L (no) 1981-05-04
PH15468A (en) 1983-01-24
GR70782B (no) 1983-03-23
KR830004201A (ko) 1983-07-06
PT72005B (en) 1981-08-31
KR840002021B1 (ko) 1984-11-05
IE50396B1 (en) 1986-04-16
ATE2667T1 (de) 1983-03-15
IL61376A0 (en) 1980-12-31
NO149102B (no) 1983-11-07
DK149308C (da) 1986-12-08
ES506893A0 (es) 1982-09-01
PT72005A (en) 1980-11-01
ES8207120A1 (es) 1982-09-01
YU42066B (en) 1988-04-30
DK149308B (da) 1986-04-28
YU3383A (en) 1983-09-30
FI803399L (fi) 1981-05-02
AU6389880A (en) 1981-05-07
FI68807C (fi) 1985-11-11
YU277480A (en) 1983-09-30
DE3062226D1 (en) 1983-04-07

Similar Documents

Publication Publication Date Title
IL61376A0 (en) Trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives and pharmaceutical compositions containing them
IL57020A (en) Carbazolyl-(4)-oxypropanolamine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PH16519A (en) 1,2,3,4-tetrahydro-2-amino-5-oxy-naphthalene derivatives and their pharmaceutical compositions
IL56206A0 (en) New 1,2-benzothiazine-1,1-doxide derivatives, their preparation and pharmaceutical compositions containing them
IL58123A0 (en) 4,5-diaryl-2-nitroimidazoles their preparation and pharmaceutical compositions containing them
IL60201A0 (en) 1,2,4-triazine derivatives,their preparation and pharmaceutical compositions containing them
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
PH15886A (en) 3-aminopropoxy derivatives,pharmaceutical compositions containing them and their use
DE3064582D1 (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives and pharmaceutical compositions containing them
IL56076A (en) 2 alpha-cyano-4 alpha,5 alpha-epoxyandrostanes,their preparation and pharmaceutical compositions containing them
GB2046259B (en) Amino-alcohol derivatives and pharmaceutical compositions containing them
DE3069074D1 (en) 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL58526A (en) 24,24-difluoro-1alpha,25-dihydroxycholecalciferol and pharmaceutical compositions containing it
IL49422A0 (en) 1-(3,3,3-triarylpropyl)-4-phenyl-4-piperidinemethanols,their preparation and pharmaceutical compositions containing them
DE3067564D1 (en) 1,2,4-triazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
IL56808A0 (en) 1-oxo-1h-pyrimido(6,1)benztheazole derivatives,process forthe preparation thereof and pharmaceutical compositions containing the same
IL61603A0 (en) 2,3-indoledione derivatives their manufacture and pharmalceutical compositions containing them
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
IL56856A0 (en) 4,5-diaryl-pyrrole derivatives,ther preparation and pharmaceutical compositions containing them
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions

Legal Events

Date Code Title Description
KB Patent renewed